Company Financials

Elevance Health Financials

United States dollar

business Elevance Health Company Profile

Main Stock Listing

NYSE: ELV

Market Capitalization $79.77 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 14.28
Forward PE 13.05
Price to Sales TTM $0.41
Price to Book MRQ $1.77
Enterprise to Revenue 0.38
Enterprise to EBITDA 8.28

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 2.84%
Operating Margin 3.46%
Return on Assets TTM 4.24%
Return on Equity TTM 12.57%

Income Statement

Revenue TTM $194,819,997,696
Revenue per Share TTM $861.18
Quarterly Revenue Growth 12.30%
Gross Profit TTM $51,162,001,408
EBITDA $8,924,000,256
Net Income to Common TTM $5,533,000,192
Diluted EPS TTM $24.54
Quarterly Earnings Growth YoY 17.00%

Balance Sheet

Total Cash MRQ $36,216,000,512
Total Cash per Share MRQ $162.96
Total Debt MRQ $
Total Debt to Equity MRQ 72.82
Current Ratio MRQ 1.56
Book Value per Share MRQ $197.95

Cash Flow

Operating Cash Flow TTM $4,912,000,000
Levered Free Cash Flow TTM $5,116,000,256

ELV Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 222,036,187
Float Shares 221,754,282
Avg 10 Volume 1,412,710
Avg 30 Volume None
Shares Short 4,764,383
Short Ratio 2.96
Short % of Shares 2.15%
% Held by Insiders 0.17%
% Held by Institutions 91.90%

Stock Price Summary

Beta 0.53
Fifty Two Week Low $273.71
Fifty Two Week High $458.75
Fifty Two Week Change -7.17%
Day 50 MA $334.48
Day 200 MA $354.30

Dividends and Splits

Forward Annual Dividend Rate $6.84
Forward Annual Dividend Yield 1.93%
Trailing Annual Dividend Rate $6.84
Trailing Annual Dividend Yield 1.93%
Payout Ratio 27.55%
Dividend Date 2025-12-19
Ex Dividend Date 2025-12-05
Last Split Factor
Last Split Date 2005-06-01